Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Mochi Health vs NextMeds

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Mochi Health logo

Mochi Health

6.6
★★★☆☆3.3/5

Best for: coaching bundled into the price rather than sold separately

Visit Mochi Health
VS
NextMeds logo

NextMeds

9.2
★★★★4.6/5

Best for: semaglutide at $79/month, 59% under the register median

Visit NextMeds

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, NextMeds opens cheaper — $79/mo against $139, and NextMeds finishes ahead, 9.2 to 6.6. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

Mochi Health

Starting dose (membership $79/mo + medication)Compounded
$139/mo
semaglutide

Membership $79/mo plus $60/mo for compounded semaglutide, read from joinmochi.com on 2026-08-14. Two qualifications the headline does not carry. The $39 membership figure the site leads with is first month only: its own footnote reads that the promotional rate applies to the first month for new customers and the standard rate is $79 per month afterwards. And $60 is a 'starting at' price marked 'price varies by dose', so it is the bottom of the ladder rather than a flat rate. $99 is shown struck through beside it.

Starting dose (membership $79/mo + medication)Compounded
$169/mo
tirzepatide

Membership $79/mo plus $90/mo for compounded tirzepatide, read from joinmochi.com on 2026-08-14. Same two qualifications as the semaglutide row: $39 is a first-month promotional membership rate and the standard rate is $79, and $90 is a 'starting at' figure marked 'price varies by dose'. $199 is shown struck through beside it.

NextMeds

InjectableCompounded
$79/mo
semaglutide

Compounded Semaglutide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $79 is the month-to-month rate read from the pricing section on 2026-08-14. The site headline reads 'from $49/mo': that is the 12-month prepaid term divided down, not a monthly price, and the ladder between them is 3-month $76, 6-month $73, 12-month $49. A summer promotion was running with a stated end of August 20, so $79 may itself be discounted.

InjectableCompounded
$109/mo
tirzepatide

Compounded Tirzepatide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $109 is the month-to-month rate read from the pricing section on 2026-08-14. The advertised 'GLP-1 + GIP: $95' is the 12-month prepaid term divided down; the ladder is 3-month $105, 6-month $100, 12-month $95. A summer promotion was running with a stated end of August 20, so $109 may itself be discounted.

What’s included

Mochi Health

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

NextMeds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Mochi Health

6.6/10

Overall

NextMeds

9.2/10

Value25%

3.0A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
7.5

Accessibility10%

4.4A
vs
B
10.0

Support10%

4.0A
vs
B
8.5

Features & Coverage

FeatureMochi HealthNextMeds
Starting Price$139/mo$79/mo
Features3 features8 features
States Available1550
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted✓ Yes
FDA WarningsNoneNone

About Mochi Health

Mochi Health is an obesity medicine telehealth seller running aggressively priced compounded GLP-1 programs.

Read our full Mochi Health review →

About NextMeds

Membership is a single flat monthly charge, and inside it sit free shipping, a registered dietitian holding a license, a care coach working 1:1, telehealth visits and the drug itself where one is prescribed. Insurance is not billed. A free assessment online goes to a licensed provider, who adds a phone or video consult in states that demand one, then prescribes if it fits. Compounding pharmacies within the Next Meds network, all licensed, ship. Auto-renewal does not exist, cancellation is open, and all 50 states can order compounded tirzepatide and semaglutide.

Read our full NextMeds review →

Pros & Cons

Mochi Health

What we like

  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers consult and coaching
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • Billed separately from the monthly figure: medication
  • Coverage is published for 15 states only, so this may not reach you
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

NextMeds

What we like

  • Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
  • Tirzepatide at $109 a month, 59% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping, coaching
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: NextMeds

NextMeds takes it, 9.2 against 6.6, and it is especially strong on semaglutide at $79/month, 59% under the register median. Mochi Health is no weak second and may fit you better on coaching bundled into the price rather than sold separately.

Choose Mochi Health if…

You want coaching bundled into the price rather than sold separately and an opening price near $139 a month.

Choose NextMeds if…

You want semaglutide at $79/month, 59% under the register median and an opening price near $79 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.0

MyDrHank

An oral route if you will not self-inject

6.0

SkinnyRx

Starting below a standard dose, with microdose tiers

8.2

YourEra

Semaglutide at $99/month, 63% under the register median

Mochi Health vs NextMeds: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring Mochi Health and NextMeds head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.